The TNFR1 antagonist Atrosimab reduces neuronal loss, glial activation and memory deficits in an acute mouse model of neurodegeneration
Ortí-Casañ, N.; Boerema, A.S. (Lid Lectoraat); Köpke, K.; Ebskamp, A.; Keijser, J.; Zhang, Y.; Chen, T.; Dolga, A.M.; Broersen, K.; Fischer, R.; Pfizenmaier, K.; Kontermann, R.E.; Eisel, U.L.M.